Clinical Trials Directory

Trials / Completed

CompletedNCT02019563

MTA/FS Pulpotomy for Vital Primary Incisors: A Randomized Controlled Trial

Mineral Trioxide Aggregate/Ferric Sulfate Pulpotomy for Vital Primary Incisors: A Randomized Controlled Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
70 (actual)
Sponsor
The Hospital for Sick Children · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

To compare radiographic and clinical outcomes and survival of mineral trioxide aggregate/ferric sulfate (MTA/FS) pulpotomy and root canal therapy (RCT) in carious vital primary maxillary incisors.

Detailed description

Dental caries is the most common chronic disease in children. Caries of the primary maxillary incisors is common in young children; often necessitating either extraction or pulp therapy. The premature loss of primary maxillary incisors can adversely affect a child's dental occlusion, ability to properly size food boluses for swallowing, speech articulation, facial esthetics and psychosocial development. Pulp treatment of cariously exposed vital primary incisors may prevent premature tooth loss as well as eliminate pain. Currently, there is a paucity of outcome investigations with regard to pulp therapy in primary incisors.

Conditions

Interventions

TypeNameDescription
PROCEDURERCT GroupAfter complete removal of all caries, if a pulp exposure is detected the pulp chamber will be opened and the pulp tissue removed. The canal will be irrigated with water and then filled with non-reinforced ZOE.
PROCEDUREMTA/FS pulpotomy GroupAfter complete removal of all caries, if a pulp exposure is detected the pulp chamber will be opened and vital coronal pulp to a depth of 2mm below free gingival margin will be removed. A solution of ferric sulfate will be applied to the amputated pulp surface and then flushed with water. MTA paste is then used to cover over the exposed amputated pulp surface.

Timeline

Start date
2010-09-01
Primary completion
2014-05-01
Completion
2014-09-01
First posted
2013-12-24
Last updated
2016-02-11
Results posted
2016-02-11

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02019563. Inclusion in this directory is not an endorsement.